The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $115.37

Today's change-1.79 -1.53%
Updated August 24 2:22 PM EDT. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $115.37

Today's change-1.79 -1.53%
Updated August 24 2:22 PM EDT. Delayed by at least 15 minutes.

Edwards Lifesciences Corp down (U.S.)$1.79

Edwards Lifesciences Corp is sharply lower today, dropping (U.S.)$1.79 or 1.53% to (U.S.)$115.37. Over the last five days, shares have gained 2.36% and are currently 2.99% off of the 52-week high. Shares have outperformed the S&P 500 by 57.18% during the last year.

Key company metrics

  • Open(U.S.) $117.21
  • Previous close(U.S.) $117.16
  • High(U.S.) $117.58
  • Low(U.S.) $115.34
  • Bid / Ask(U.S.) $115.34 / (U.S.) $115.38
  • YTD % change+46.07%
  • Volume800,239
  • Average volume (10-day)1,320,563
  • Average volume (1-month)1,364,911
  • Average volume (3-month)1,588,028
  • 52-week range(U.S.) $62.53 to (U.S.) $118.92
  • Beta0.61
  • Trailing P/E47.73×
  • P/E 1 year forward40.76×
  • Forward PEG2.30×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.42
Updated August 24 2:22 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.72%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue759697671616
Total other revenue--------
Total revenue759697671616
Gross profit557517495469
Total cost of revenue203180176147
Total operating expense590514504465
Selling / general / administrative229213222212
Research & development11310298101
Depreciation / amortization--------
Interest expense (income), net operating----54
Unusual expense (income)441232
Other operating expenses, total9510
Operating income169183167151
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax169183167151
Income after tax127143141118
Income tax, total42402633
Net income127143141118
Total adjustments to net income--------
Net income before extra. items127143141118
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items127143141118
Inc. avail. to common incl. extra. items127143141118
Diluted net income127143141118
Dilution adjustment--010
Diluted weighted average shares217218221220
Diluted EPS excluding extraordinary itemsvalue per share0.580.660.640.54
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.730.700.650.55